AstraZeneca resumes UK trial of COVID-19 vaccine
AstraZeneca and the University of Oxford said they are restarting the UK trial of their COVID-19 vaccine candidate after an unexplained illness in one participant prompted them to pause studies. A safety review in the UK was completed, and the drugmaker said it is working with regulatory authorities around the world to determine next steps for studies in other countries. The Hill (9/12)
Read full article now.
Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!